In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 29th, 2005 | 28 | No |
4-[4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL]-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.49 | -5.05 | -25.61 | 2 | 7 | 0 | 101 | 425.89 | 6 | ↓ |
Hi High (pH 8-9.5) | 2.49 | -4.49 | -67.73 | 1 | 7 | -1 | 104 | 424.882 | 6 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.15e-02 g/l | DrugBank-experimental |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA17-2-E | ADAM17 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 440 | 0.32 | Binding ≤ 10μM |
MMP1-1-E | Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 800 | 0.30 | Binding ≤ 10μM |
MMP13-2-E | Matrix Metalloproteinase 13 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 2 | 0.43 | Binding ≤ 10μM |
MMP14-2-E | Matrix Metalloproteinase 14 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 14 | 0.39 | Binding ≤ 10μM |
MMP2-1-E | 72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
MMP3-1-E | Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 9 | 0.40 | Binding ≤ 10μM |
MMP7-1-E | Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.28 | Binding ≤ 10μM |
MMP9-1-E | Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 3 | 0.43 | Binding ≤ 10μM |
Z102240-1-O | Cartilage (cluster #1 Of 1), Other | Other | 30 | 0.38 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA17_HUMAN | P78536 | ADAM17, Human | 176 | 0.34 | Binding ≤ 1μM |
MMP13_HUMAN | P45452 | Matrix Metalloproteinase 13, Human | 0.28 | 0.48 | Binding ≤ 1μM |
MMP14_HUMAN | P50281 | Matrix Metalloproteinase 14, Human | 14 | 0.39 | Binding ≤ 1μM |
MMP3_HUMAN | P08254 | Matrix Metalloproteinase 3, Human | 7.1 | 0.41 | Binding ≤ 1μM |
MMP9_HUMAN | P14780 | Matrix Metalloproteinase 9, Human | 0.55 | 0.46 | Binding ≤ 1μM |
MMP1_HUMAN | P03956 | Matrix Metalloproteinase-1, Human | 233 | 0.33 | Binding ≤ 1μM |
MMP2_HUMAN | P08253 | Matrix Metalloproteinase-2, Human | 0.22 | 0.48 | Binding ≤ 1μM |
ADA17_HUMAN | P78536 | ADAM17, Human | 176 | 0.34 | Binding ≤ 10μM |
MMP13_HUMAN | P45452 | Matrix Metalloproteinase 13, Human | 0.28 | 0.48 | Binding ≤ 10μM |
MMP14_HUMAN | P50281 | Matrix Metalloproteinase 14, Human | 14 | 0.39 | Binding ≤ 10μM |
MMP3_HUMAN | P08254 | Matrix Metalloproteinase 3, Human | 7.1 | 0.41 | Binding ≤ 10μM |
MMP7_HUMAN | P09237 | Matrix Metalloproteinase 7, Human | 1200 | 0.30 | Binding ≤ 10μM |
MMP9_HUMAN | P14780 | Matrix Metalloproteinase 9, Human | 0.55 | 0.46 | Binding ≤ 10μM |
MMP1_HUMAN | P03956 | Matrix Metalloproteinase-1, Human | 233 | 0.33 | Binding ≤ 10μM |
MMP2_HUMAN | P08253 | Matrix Metalloproteinase-2, Human | 0.22 | 0.48 | Binding ≤ 10μM |
Z102240 | Z102240 | Cartilage | 30 | 0.38 | Functional ≤ 10μM |
Description | Species |
---|---|
Activated NOTCH1 Transmits Signal to the Nucleus | |
Activation of Matrix Metalloproteinases | |
Assembly of collagen fibrils and other multimeric structures | |
Basigin interactions | |
Collagen degradation | |
Constitutive Signaling by NOTCH1 HD Domain Mutants | |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | |
Degradation of the extracellular matrix | |
EGFR Transactivation by Gastrin | |
EPH-ephrin mediated repulsion of cells | |
Growth hormone receptor signaling | |
Nuclear signaling by ERBB4 | |
Regulated proteolysis of p75NTR | |
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l | |
Release of Hh-Np from the secreting cell | |
Signaling by EGFR | |
Signaling by SCF-KIT | |
TNF signaling |